Home-based Chemotherapy Proves To Be Safe And Feasible In Pilot Study

In a study published successful NEJM Catalyst, Mayo Clinic researchers person demonstrated that chemotherapy can beryllium safely delivered successful patients' homes.

The study evaluated Mayo Clinic's Cancer CARE Beyond Walls (Connected Access and Remote Expertise), a exemplary that combines virtual care, distant diligent monitoring and in-home objective services to present crab curen extracurricular accepted infusion centers.

In nan aviator study, a multidisciplinary squad delivered 93 IV chemotherapy infusions to 10 patients successful their homes. Researchers reported nary treatment-related infusion reactions aliases catheter-related infections, supporting nan information and feasibility of this approach.

"Cancer attraction has traditionally required patients to walk agelong hours successful infusion centers, often acold from home," says Roxana Dronca, M.D., tract head of nan Mayo Clinic Comprehensive Cancer Center successful Florida and head of Mayo Clinic Cancer CARE Beyond Walls. "This exemplary allows america to safely bring high-quality attraction straight to patients, reducing load while maintaining nan standards patients expect from Mayo Clinic."

The study highlights nan imaginable of home-based chemotherapy to trim nan physical, affectional and financial burdens associated pinch crab treatment. Patients avoided recreation clip and knowledgeable less disruptions to regular life while maintaining a continuous relationship pinch their attraction squad done virtual visits and distant monitoring.

Most participants surveyed reported precocious restitution pinch at-home attraction and said they would urge nan exemplary to others.

"This attack is astir much than convenience," Dr. Dronca says. "It's astir improving value of life during curen and expanding entree to attraction for patients who whitethorn look barriers to reaching accepted crab centers."

To build connected these findings, Mayo Clinic is still enrolling patients successful a randomized objective proceedings that launched successful August 2023 to measure home-based chemotherapy compared pinch modular infusion care. This study will analyse safety, diligent experience, outcomes and costs, pinch nan extremity of expanding entree to high-quality crab attraction and reducing barriers to objective proceedings participation.

Dr. Dronca is nan first writer of nan aviator study, and Cheryl Willman, M.D., nan Stephen and Barbara Slaggie Executive Director, Mayo Clinic Cancer Programs, is nan elder author. For a complete database of authors, disclosures and funding, reappraisal the study.